基本信息
浏览量:4
职业迁徙
个人简介
The Precision Vaccines Program (PVP) is an academic research program that applies precision medicine principles to vaccinology to discover and develop next generation vaccines tailored to vulnerable populations. It conducts basic and translational research to develop novel vaccines and therapeutics for diseases that affect vulnerable populations such as infants, older adults, those with chronic disease and those who are immunocompromised. The PVP employs approaches such as modeling vaccine-induced human immune responses in vitro using a variety of platforms, adjuvant screening/discovery, systems biology, animal studies, and clinical trials to accelerate and de-risk development of vaccines optimized for populations with distinct immune responses, including those at the extremes of age who suffer the most infections. PVP faculty lead several NIH/NIAID-supported studies, including: (a) Adjuvant Discovery and Development Program contracts, leveraging robotic and immunologic approaches to discover, characterize, and formulate novel small molecule adjuvants that may enhance vaccine responses of the young and the elderly; (b) an international Human Immunology Project Consortium effort employing systems biology to define biomarkers of neonatal vaccine immunogenicity; (c) coronavirus/COVID-related studies including a national effort to discover biomarkers of COVID disease severity and a project to discover and develop novel coronavirus vaccines; (d) development of adjuvanted vaccines to prevent pertussis (whooping cough), respiratory syncytial virus, and HIV as well as overdose in opioid users; and (e) an Immune Development in Early Life (IDEAL) study that aims to increase infant vaccine responsiveness and decrease childhood respiratory disease.
研究兴趣
论文共 331 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sanya Thomas,Jensen Pak,Simon Doss-Gollin, Kevin Ryff, Elisabeth Beijnen,Gabriel K. Pedersen,Dennis Christensen,Ofer Levy,Simon D. van Haren
Frontiers in Immunology (2024)
Avery's Diseases of the Newbornpp.409-438.e8, (2024)
Julie Zimmermann,Simon D. van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan,Katharina Wørzner, Ricki T. Krog,Safia Guleed, Tu Hu,Rasmus Mortensen,Jes Dietrich,Sara M. Ø. Solbak,Ofer Levy,
npj Vaccinesno. 1 (2024): 13-13
Nature communicationsno. 1 (2024): 216-216
Science translational medicineno. 743 (2024): eadj5154-eadj5154
Julie Zimmermann,Simon D. van Haren,Joann Diray-Arce, Ignatius Ryan Adriawan,Katharina Worzner, Ricki T. Krog,Safia Guleed, Tu Hu,Rasmus Mortensen,Jes Dietrich, Sara M. o. Solbak,Ofer Levy,
Hoang Van Phan, Alexandra Tsitsiklis,Cole P Maguire,Elias K Haddad,Patrice M Becker,Seunghee Kim-Schulze,Brian Lee,Jing Chen,Annmarie Hoch,Harry Pickering,Patrick Van Zalm,Matthew C Altman,
medRxiv : the preprint server for health sciences (2024)
eBioMedicine (2023): 104860-104860
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn